Raltegravir: The evidence of its therapeutic value in HIV-1 infection

by Ramkumar, Kavya, Neamati, Nouri
Published 2010

Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors

by Neamati Nouri, Ramkumar Kavya, Odde Srinivas, Serrao Erik
Published 2009-04-01

Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors

by Serrao, Erik, Odde, Srinivas, Ramkumar, Kavya, Neamati, Nouri
Published 2009

Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors

by Serrao, Erik, Odde, Srinivas, Ramkumar, Kavya, Neamati, Nouri
Published 2009

The hydroxyquinoline analog YUM70 inhibits GRP78 to induce ER stress-mediated apoptosis in pancreatic cancer

by Samanta, Soma, Yang, Suhui, Debnath, Bikash, Xue, Ding, Kuang, Yuting, Ramkumar, Kavya, Lee, Amy S., Ljungman, Mats, Neamati, Nouri
Published in Cancer Res (2021)

Design, Synthesis and Structure-activity Studies of Rhodanine Derivatives as HIV-1 Integrase Inhibitors

by Ramkumar, Kavya, Yarovenko, Vladimir N., Nikitina, Alexandra S., Zavarzin, Igor V., Krayushkin, Mikhail M., Kovalenko, Leonid V., Esqueda, Adrian, Odde, Srinivas, Neamati, Nouri
Published in Molecules (2010)

Mechanistic evaluation and transcriptional signature of a glutathione S-transferase omega 1 inhibitor

by Ramkumar, Kavya, Samanta, Soma, Kyani, Anahita, Yang, Suhui, Tamura, Shuzo, Ziemke, Elizabeth, Stuckey, Jeanne A., Li, Si, Chinnaswamy, Krishnapriya, Otake, Hiroyuki, Debnath, Bikash, Yarovenko, Vladimir, Sebolt-Leopold, Judith S., Ljungman, Mats, Neamati, Nouri
Published in Nat Commun (2016)

Combination treatment of the oral CHK1 inhibitor, SRA737 and low dose gemcitabine, enhances the effect of PD-L1 blockade by modulating the immune microenvironment in small cell lun...

by Sen, Triparna, Della Corte, Carminia M., Milutinovic, Snezana, Cardnell, Robert J, Diao, Lixia, Ramkumar, Kavya, Gay, Carl M., Stewart, C Allison, Fan, Youhong, Shen, Li, Hansen, Ryan J., Strouse, Bryan, Hedrick, Michael P., Hassig, Christian A., Heymach, John V., Wang, Jing, Byers, Lauren A
Published in J Thorac Oncol (2019)

AXL inhibition induces DNA damage and replication stress in non-small cell lung cancer cells and promotes sensitivity to ATR inhibitors

by Ramkumar, Kavya, Stewart, C. Allison, Cargill, Kasey R., Corte, Carminia M. Della, Wang, Qi, Shen, Li, Diao, Lixia, Cardnell, Robert J., Peng, David H., Rodriguez, B. Leticia, Fan, You-Hong, Heymach, John V., Wang, Jing, Gay, Carl M., Gibbons, Don L., Byers, Lauren A.
Published in Mol Cancer Res (2020)

STING pathway expression identifies non-small cell lung cancers with an immune-responsive phenotype

by Corte, Carminia M. Della, Sen, Triparna, Gay, Carl M., Ramkumar, Kavya, Diao, Lixia, Cardnell, Robert J., Rodriguez, B. Leticia, Stewart, C. Allison, Papadimitrakopoulou, Vassiliki A., Gibson, Laura, Fradette, Jared J., Wang, Qi, Fan, Youhong, Peng, David H., Negrao, Marcelo V., Witsuba, Ignacio I., Fujimoto, Junya, Soto, Luisa M. Solis, Behrens, Carmen, Skoulidis, Ferdinandos, Heymach, John V., Wang, Jing, Gibbons, Don L., Byers, Lauren A.
Published in J Thorac Oncol (2020)

Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology

by Stewart, C. Allison, Gay, Carl M., Ramkumar, Kavya, Cargill, Kasey R., Cardnell, Robert J., Nilsson, Monique B., Heeke, Simon, Park, Elizabeth M., Kundu, Samrat T., Diao, Lixia, Wang, Qi, Shen, Li, Xi, Yuanxin, Zhang, Bingnan, Della Corte, Carminia Maria, Fan, Youhong, Kundu, Kiran, Gao, Boning, Avila, Kimberley, Pickering, Curtis R., Johnson, Faye M., Zhang, Jianjun, Kadara, Humam, Minna, John D., Gibbons, Don L., Wang, Jing, Heymach, John V., Byers, Lauren Averett
Published in bioRxiv (2021)

Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2–Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology

by Stewart, C. Allison, Gay, Carl M., Ramkumar, Kavya, Cargill, Kasey R., Cardnell, Robert J., Nilsson, Monique B., Heeke, Simon, Park, Elizabeth M., Kundu, Samrat T., Diao, Lixia, Wang, Qi, Shen, Li, Xi, Yuanxin, Zhang, Bingnan, Della Corte, Carminia Maria, Fan, Youhong, Kundu, Kiran, Gao, Boning, Avila, Kimberley, Pickering, Curtis R., Johnson, Faye M., Zhang, Jianjun, Kadara, Humam, Minna, John D., Gibbons, Don L., Wang, Jing, Heymach, John V., Byers, Lauren Averett
Published in J Thorac Oncol (2021)

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

by Gay, Carl M., Allison Stewart, C., Park, Elizabeth M., Diao, Lixia, Groves, Sarah M., Heeke, Simon, Nabet, Barzin Y., Fujimoto, Junya, Solis, Luisa M., Lu, Wei, Xi, Yuanxin, Cardnell, Robert J., Wang, Qi, Fabbri, Giulia, Cargill, Kasey R., Vokes, Natalie I., Ramkumar, Kavya, Zhang, Bingnan, Della Corte, Carminia M., Robson, Paul, Swisher, Stephen G., Roth, Jack A., Glisson, Bonnie S., Shames, David S., Wistuba, Ignacio I., Wang, Jing, Quaranta, Vito, Minna, John, Heymach, John V., Byers, Lauren Averett
Published in Cancer Cell (2021)